Thromboxane A2-mediated Cl- secretion induced by platelet-activating factor in isolated rat colon

European Journal of Pharmacology

Volumn 400, Issue 2-3, 2000, Pages 297-303

  Suzuki, Tomoyuki ^a   Sakai, Hideki ^a   Takeguchi, Noriaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cl secretion; Colon; PAF (platelet activating factor); rat; Thromboxane A2

Indexed keywords

11 [2 (5,6 DIMETHYL 1 BENZIMIDAZOLYL)ETHYLIDENE] 6,11 DIHYDRODIBENZ[B,E]OXEPINE 2 CARBOXYLIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 [ALPHA HYDROXY 5 (1 IMIDAZOLYL) 2 METHYLBENZYL] 3,5 DIMETHYLBENZOIC ACID; 5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; FUROSEMIDE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; COLON; COLON MUCOSA; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZIMIDAZOLES; BENZOXEPINS; CARRIER PROTEINS; CHLORIDES; COLON; DINOPROSTONE; ENZYME INHIBITORS; FEMALE; IMIDAZOLES; INDOLES; INTESTINAL MUCOSA; LIPOXYGENASE INHIBITORS; MEMBRANE PROTEINS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE; SECRETORY RATE; THROMBOXANE A2; THROMBOXANE-A SYNTHASE;

EID: 0034698373     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00405-2     Document Type: Article

References (40)

1. Appleyard C.B., Hillier K. Biosynthesis of platelet-activating factor in normal and inflamed human colon mucosa: evidence for the involvement of the pathway of platelet-activating factor synthesis de novo in inflammatory bowel disease. Clin. Sci. 88:1995;713-717.
2. Bern M.J., Sturbaum C.W., Karayalcin S.S., Berschneider H.M., Wachsman J.T., Powell D.W. Immune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and enteric nervous system. J. Clin. Invest. 83:1989;1810-1820.
3. Borman R.A., Jewell R., Hillier K. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. Br. J. Pharmacol. 123:1998;231-236.
4. Braquet P., Touqui L., Shen T.Y., Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:1987;97-145.
5. Buckley T.L., Hoult J.R.S. Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors. Eur. J. Pharmacol. 163:1989;275-283.
6. Calderaro V., Giovane A., De Simone B., Camussi G., Rossiello R., Quagliuolo L., Servillo L., Taccone W., Giordano C., Balestrieri C. Arachidonic acid metabolites and chloride secretion in rabbit distal colonic mucosa. Am. J. Physiol. 261:1991;G443-G450.
7. Casellas F., Papo M., Guarner F., Antolín M., Segura R.M., Armengol J.R., Malagelada J.-R. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 7:1995;221-226.
8. -) co-transport system. Clin. Sci. 71:1986;465-476.
9. Coleman R.A., Smith W.L., Narumiya S. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:1994;205-229.
10. Denizot Y., Chaussade S., Nathan N., Colombel J.F., Bossant M.-J., Cherouki N., Benveniste J., Couturier D. PAF-acether and acetylhydrolase in stool of patients with Crohn's disease. Dig. Dis. Sci. 37:1992;432-437.
11. - in rat descending colon. Acta Physiol. Scand. 137:1989;215-222.
12. Diener M., Bridges R.J., Knobloch S.F., Rummel W. Neuronally mediated and direct effects of prostaglandins on ion transport in rat colon descendens. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;74-78.
13. Dixon R.A.F., Diehl R.E., Opas E., Rands E., Vickers P.J., Evans J.F., Gillard J.W., Miller D.K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 343:1990;282-284.
14. Eliakim R., Karmeli F., Razin E., Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Gastroenterology. 95:1988;1167-1172.
15. Ferraris L., Karmeli F., Eliakim R., Klein J., Fiocchi C., Rachmilewitz D. Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut. 34:1993;665-668.
16. 2 and E-series prostaglandins. J. Immunol. 144:1990;3489-3497.
17. 2 receptors in isolated rabbit colonic crypt cells. Am. J. Physiol. 268:1995;G270-G275.
18. - secretion in rat distal colon in vitro. Am. J. Physiol. 265:1993;G467-G473.
19. 2+ pathway in rat colonic crypt cells. Biochem. Biophys. Res. Commun. 258:1999;708-712.
20. Izzo A.A. PAF and the digestive tract. J. Pharm. Pharmacol. 48:1996;1103-1111.
21. Kald B., Olaison G., Sjödahl R., Tagesson C. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa. Digestion. 46:1990;199-204.
22. 2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11-dihydrodibenz[b, e] oxepine-2-carboxylate monohydrate on smooth muscle preparations. Arzneim.-Forsch./Drug Res. 41:1991;1237-1241.
23. Katsura M., Miyamoto T., Hamanaka N., Kondo K., Terada T., Ohgaki Y., Kawasaki A., Tsuboshima M. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives). Adv. Prostaglandin, Thromboxane, Leukotriene Res. 11:1983;351-357.
24. Longo W.E., Polities G., Vernava A.M. III, Deshpande Y., Niehoff M., Chandel B., Kulkarni A., Kaminski D.L. Platelet-activating factor mediates trinitrobenzene induced colitis. Prostaglandins Leukotrienes Essent. Fatty Acids. 51:1994;419-424.
25. Longo W.E., Carter J.D., Chandel B., Niehoff M., Standeven J., Deshpande Y., Vernava A.M., Polites G., Kulkarni A.D., Kaminski D.L. Evidence for a colonic PAF receptor. J. Surg. Res. 58:1995;12-18.
26. Mascolo N., Izzo A.A., Autore G., Maiello F.M., Di Carlo G., Capasso F. Acetic acid-induced colitis in normal and essential fatty acid deficient rats. J. Pharmacol. Exp. Ther. 272:1995;469-475.
27. Meenan J., Grool T.A., Hommes D.W., Dijkhuizen S., ten Kate F.J., Wood M., Whittaker M., Tytgat G.N., van Deventer S.J. Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur. J. Gastroenterol. Hepatol. 8:1996;569-573.
28. Mikashima H., Ochi H., Muramoto Y., Yasuda H., Tsuruta M., Maruyama Y. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function. Thromb. Res. 43:1986;455-468.
29. 2 antagonist, on human, guinea pig and rat platelets. Jpn. J. Pharmacol. 59:1992;357-364.
30. Nassif A., Longo W.E., Mazuski J.E., Vernava A.M., Kaminski D.L. Role of cytokines and platelet-activating factor in inflammatory bowel disease: implications for theraphy. Dis. Colon Rectum. 39:1996;217-223.
31. Rampton D.S., Collins C.E. Thromboxanes in inflammatory bowel disease-pathogenic and therapeutic implications. Aliment. Pharmacol. Ther. 7:1993;357-367.
32. - secretion induced by the antitumor drug, irinotecan (CPT-11), in the rat colon. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;309-314.
33. - secretion in isolated rat colon. J. Physiol. (London). 505:1997;133-144.
34. Sobhani I., Hochlaf S., Denizot Y., Vissuzaine C., Rene E., Benveniste J., Lewin M.M.J., Mignon M. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut. 33:1992;1220-1225.
35. 2 receptor antagonist in an animal model of inflammatory bowel disease. Digestion. 58:1997;476-478.
36. Tozaki H., Fujita T., Odoriba T., Terabe A., Suzuki T., Tanaka C., Okabe S., Muranishi S., Yamamoto A. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci. 64:1999;1155-1162.
37. Travis S.P.L., Jewell D.P. Regional differences in the response to platelet-activating factor in rabbit colon. Clin. Sci. 82:1992;673-680.
38. Travis S.P.L., Crotty B., Jewell D.P. Site of action of platelet-activating factor within the mucosa of rabbit distal colon. Clin. Sci. 88:1995;51-57.
39. Vilaseca J., Salas A., Guarner F., Rodriguez R., Malagelada J.-R. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology. 98:1990;269-277.
40. Wardle T.D., Hall L., Turnberg L.A. Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion. Gut. 38:1996;355-361.